Leukemia

Course of chronic myeloid leukemia in the elderly is not different

Published in Blood Weekly, November 13th, 2003

Course of chronic myeloid leukemia in the elderly is not different.

According to recent research from Germany, "Chronic myeloid leukemia (CML) in older patients has not been studied well.

"To assess the long-term outcome of older patients with Philadelphia- and/or BCR-ABL-positive CML, 199 patients aged greater than or equal to 60 years representing 23% of 856 patients enrolled in the German randomized CML-studies I (interferon alpha (IFN) vs. hydroxyurea (HU) vs. busulfan (BU) and II (IFN+ HU vs. HU alone) were analyzed after a median observation time of 7 years," wrote U. Berger and colleagues, University of Heidelberg.

"In all,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-11-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry